Showing results (2251-2260 of 2,459) with videos related to

Sort By:
Pageof 246
American Journal of Surgery|November 22, 2016
Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care centerJames M Chang, Heidi E Kosiorek, Amylou C Dueck, et al.
World Journal of Transplantation|March 11, 2017
International kidney paired donation transplantations to increase kidney transplant of O group and highly sensitized patient: First report from IndiaVivek B Kute, Himanshu V Patel, Pankaj R Shah, et al.
Biological Psychiatry|November 24, 2015
Neuron-Targeted Caveolin-1 Improves Molecular Signaling, Plasticity, and Behavior Dependent on the Hippocampus in Adult and Aged MiceChitra D Mandyam, Jan M Schilling, Weihua Cui, et al.
Genome Biology and Evolution|May 19, 2016
Opsin Repertoire and Expression Patterns in Horseshoe Crabs: Evidence from the Genome of Limulus polyphemus (Arthropoda: Chelicerata)Barbara-Anne Battelle, Joseph F Ryan, Karen E Kempler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 2, 2025
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe AsthmaJohn Busby, Joshua Holmes, Mohammed Almutairi, et al.
Arxiv|June 12, 2025
Diffusion Transformer-based Universal Dose Denoising for Pencil Beam Scanning Proton TherapyYuzhen Ding, Jason Holmes, Hongying Feng, et al.
Biological Psychiatry Global Open Science|July 31, 2023
The Road Not Taken: Disconnection of a Human-Unique Cortical Pathway Underlying Naturalistic Social Perception in SchizophreniaGaurav H Patel, David C Gruskin, Sophie C Arkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2023
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative groupDerek A Mumaw, Allison J Hazy, Aleksander Vayntraub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other RearrangementTimil H Patel, Leigh Marcus, M Naomi Horiba, et al.
Pageof 246